Bibliografie:

1.Gross P.M., 2007 - Pomegranate punicalagins: Ancient aril antioxidants, Natural 
 Products Information Center. 
2.Seeram N.P., Henning S.M., Zhang Y., Suchard M., Li Z., Heber D., 2006 - Pomegranate
 juice ellagitannin metabolites are present in human plasma and some persist in urine 
 for up to 48 hours, J Nutr. 136 (10): 2481–5. 
3.Mertens-Talcott S.U., Jilma-Stohlawetz P., Rios J., Hingorani L., Derendorf H.,
 2006 - Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum L.)
 polyphenols after ingestion of a standardized extract in healthy human volunteers, 
 J Agric Food Chem. 54 (23): 8956–61. 
4.Seeram N.P., Lee R., Heber D., 2004 - Bioavailability of ellagic acid in human plasma
 after consumption of ellagitannins from pomegranate (Punica granatum L.) juice,
 Clin Chim Acta, 348 (1-2): 63–8.
5.Aviram M., Rosenblat M., Gaitini D., et al, 2004 - Pomegranate juice consumption for
 3 years by patients with carotid artery stenosis reduces common carotid intima-media
 thickness, blood pressure and LDL oxidation, Clin Nutr, 23 (3): 423–33. 
6.Esmaillzadeh A., Tahbaz F., Gaieni I., Alavi-Majd H., Azadbakht L., 2004 - Concentrated
 pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia, 
 J Med Food, 7 (3): 305–8. 
7.Kaplan M, Hayek T, Raz A, et al (Aug 2001). "Pomegranate juice supplementation to 
 atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol
 accumulation and development of atherosclerosis". J Nutr. 131 (8): 2082–9. 
8.Aviram M., Dornfeld L., 2001 - Pomegranate juice consumption inhibits serum angiotensin
 converting enzyme activity and reduces systolic blood pressure. 
9. Neurath A.R., Strick N., Li Y.Y., Debnath A.K., 2004 - Punica granatum (Pomegranate) 
 juice provides an HIV-1 entry inhibitor and candidate topical microbicide, BMC Infect.
 Dis., 4: 41. 
10.Menezes S.M., Cordeiro L.N., Viana G.S., 2006 - Punica granatum (pomegranate) extract
 is active against dental plaque, Journal of herbal pharmacotherapy,  6 (2): 79–92. 
11.Kim N.D., Mehta R., Yu W., et al, 2002 - Chemopreventive and adjuvant therapeutic 
 potential of pomegranate (Punica granatum) for human breast cancer,. Breast Cancer Res
 Treat., 71 (3): 203–17.
12.Seeram N.P., Aronson W.J., Zhang Y., et al, 2007 - Pomegranate ellagitannin-derived
 metabolites inhibit prostate cancer growth and localize to the mouse prostate gland,
 J. Agric. Food Chem.,  55 (19): 7732–7.